Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jun 2026 for Akebia Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Michael W. Rogers: trading record in brief
All filings by Michael W. Rogers on record concern Akebia Therapeutics, Inc., in the capacity of board member. The record holds 6 filings, for trades running from 2 June 2021 to 17 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 22 June 2026 with a share grant in Akebia Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael W. Rogers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
35,700 sharesCommon StockSEC:0001244159-26-000001:0
35,700 shares0Common StockSEC:0001562180-25-004720:0
30,000 shares0Common StockSEC:0001562180-24-004907:0
30,000 shares0Common StockSEC:0001562180-23-004959:0
13,700 shares0Common StockSEC:0001562180-22-004976:0
13,700 shares0Common StockSEC:0001562180-21-004029:0
6 of 6 declarations
